Nestlé Health Science to acquire VOWST assets from Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) has announced a significant development in its partnership with Nestlé Health Science—a non-binding memorandum of understanding whereby Nestlé Health Science will acquire certain tangible and intangible assets related to VOWST (fecal microbiota spores, live-brpk) capsules. This pivotal transaction will grant Nestlé Health Science full control over the development, commercialization, and […]